LARIFIKEHL drops D 5, Smallpox, Tuberculosis
Laricifomes officinalis homeopathy benefits:
The species epithet "officinalis" denotes an organism associated with herbalism or medicine; L. officinalis was used by the Ancient Greeks to treat consumption (tuberculosis) according to the writings of Pedanius Dioscorides in 65 AD, and by some indigenous people to treat smallpox.
pack size:10ml Dosage form:drops
Homeopathic Smallpox, Tuberculosis, LARIFIKEHL drops D 5 medicine.
active Smallpox, Tuberculosis, LARIFIKEHL drops D 5 ingredients
- 1 ml Laricifomes officinalis e volumine mycelii (lyophil., sterile.) D5
ingredients
- water, purified
Dosage form:
drops for ingestion and rubbing in
Preparation group:
fungal preparation Active
substance:
Laricifomes officinalis e volumine mycelii (lyophil., sterile.) D5
Smallpox, Tuberculosis, LARIFIKEHL drops D 5 Composition:
10 ml contain: 10 ml Laricifomes officinalis e volumine mycelii (lyophil., sterile.) D5 dil. (HAB, regulation 5a, solution D1 with purified water).
Experience has shown that it is used for:
Registered homeopathic medicinal product, therefore without indication of a therapeutic indication.
Smallpox, Tuberculosis, LARIFIKEHL drops D 5 Application:
For oral use: Adults and adolescents from the age of 12 take 8 drops once a day before a meal. For rubbing into the skin: Unless otherwise directed, adults and adolescents aged 12 and over rub 5 - 10 drops twice a week at the site of the disease or in the crook of the arm. Larifikehl® D5 should be discontinued after a maximum of 4 weeks of therapy.
Side effects:
Due to the content of specific components in Larifikehl® D5, hypersensitivity reactions, mainly in the form of skin reactions, can occur in rare cases and an allergy to the component Laricifomes officinalis can be triggered. The drug should then be discontinued and a doctor consulted.
Contraindications:
Do not use with
- Hypersensitivity to Laricifomes officinalis
- Autoimmune diseases
- Children under 12 years of age
- Pregnant and breastfeeding women
Interactions:
Other immunosuppressive drugs can impair the effectiveness of Larifikehl® D5. An interval of 4 weeks should be observed before and after treatment with orally administered live vaccines.
Precautions:
None known.